CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Transcranial Direct Current Stimulation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05582616
NCT05582616N/ACompleted
CompareCT.gov

The Safety and Feasibility of Transcranial Direct Current Stimulation Combined With Conservative Treatment for Cervicogenic Headaches

University of Calgary·interventional·Posted Oct 17, 2022·Updated Jun 27, 2024

In Brief

A clinical study evaluating Transcranial Direct Current Stimulation and Sham Transcranial Direct Current Stimulation for Cervicogenic Headache. Completed, enrolled 32 participants across 1 site.

Detailed Summary

Annually, up to 150,000 individuals are affected by cervicogenic headaches (CGH) in Canada with many of these cases being chronic. Current treatments for CGH are limited in efficacy and durability - indicating a dire need for novel interventions in this population. Transcranial direct current stimulation (tDCS) and physiotherapy have a high degree of safety and have been studied as interventions for many other chronic pain conditions and headache disorders. We propose to study the feasibility and safety of tDCS alongside physiotherapy for CGH further in a randomized sham controlled trial.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCervicogenic Headache
CountriesCanada
CollaboratorsAlberta Health services

Timeline

N/ACompletedFinished
2023202420252026
First PostedOct 17, 2022
Enrollment StartNov 3, 2022
Primary CompletionApr 24, 2024
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 3.7 years ago

Interventions

Transcranial Direct Current Stimulationdevice

See treatment arm description

Sham Transcranial Direct Current Stimulationdevice

See sham comparator arm description